Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.9B | 1.8B | 2.1B | 2.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 75M | 77M | 78M | 88M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 19M | 19M | 19M | 19M |
| Other income expense | 27M | 27M | 32M | 26M |
| Pretax income | 229M | 197M | 320M | 229M |
| Tax provision | 55M | 43M | 65M | 48M |
| Net income | 174M | 154M | 255M | 181M |
| Basic EPS | 2.1 | 1.8 | 3.0 | 2.2 |
| Diluted EPS | 2.1 | 1.8 | 3.0 | 2.2 |
| Basic average shares | 83.5M | 83.8M | 84.0M | 83.9M |
| Diluted average shares | 83.5M | 83.8M | 84M | 83.9M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 174M | 154M | 255M | 181M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |